West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 91/100

West Pharmaceutical Services Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 06:45PM GMT
Juan Esteban Avendano
BofA Securities, Research Division - Associate

I am Juan Avendano. I am part of the life biosciences tools equity research team led by Derik De Bruin at Bank of America. I focus on biopharma services, namely CROs and CDMOs. I'd like to thank everyone on the webcast for their participation, and please feel free to submit your questions through Veracast.

It is my pleasure to conduct the following fireside chat with West Pharmaceutical Services. We're joined by their CEO, Eric Green; their CFO, Bernard Birkett; and Quintin Lai from Investor Relations.

Eric and team, thank you once again for being here. To set the stage, would you like to do a few opening remarks?

Eric M. Green
West Pharmaceutical Services, Inc. - President, CEO & Director

Yes. Juan, first of all, thank you for the opportunity to participate in your events. It's been a really good day for us. And I'll just add a couple of comments before we get into the Q&A.

But when you think about since the start of the pandemic, our priorities have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot